Renal function and oral anticoagulant treatment of incident non-valvular atrial fibrillation: a retrospective study.
-
アブストラクト Aim:To describe the renal function of individuals newly diagnosed with non-valvular atrial fibrillation in England, and describe how oral anticoagulant (OAC) treatment varies according to renal function. Patients & methods: We identified a cohort of individuals with non-valvular atrial fibrillation (n = 18,419) and described their renal function at diagnosis and the prevalence of OAC treatment initiation by renal function.Results:79% of individuals had some evidence of renal dysfunction with 12% having a glomerular filtration rate <30 ml/min/1.73 m(2). OAC treatment initiation in the 6 months following diagnosis was lower in individuals with severe renal dysfunction than in those with normal renal function.Conclusion:The high prevalence of renal dysfunction and low OAC treatment prevalence highlights the need for additional evidence regarding OACs in individuals with severe renal dysfunction.ジャーナル名 Future cardiology 投稿日 2019/5/30 投稿者 Ramagopalan, Sreeram V; Stamp, Elaine; Sammon, Cormac J; Besford, Megan; Carroll, Robert; Mehmud, Faisal; Alikhan, Raza 組織名 Centre for Observational Research & Data Sciences, Bristol-Myers Squibb, UB8 1DH,;UK.;PHMR, Berkeley Works, London, NW1 8XY, UK.;Bristol-Myers Squibb, Uxbridge, UB8 1DH, UK.;Department of Haematology, University Hospital of Wales, Cardiff & Vale;University Health Board, Cardiff, CF14 4XW, UK. Pubmed リンク https://www.ncbi.nlm.nih.gov/pubmed/31140872/ -
お問合わせ
検索
メルマガ登録
